COSMOS HEALTH INC (COSM) Stock Price, Quote, News and Overview
NASDAQ:COSM - Nasdaq - US2214133058 - Common Stock - Currency: USD
COSM Quote, Performance and Key Statistics
NASDAQ:COSM (5/9/2025, 11:41:20 AM)
0.4161
-0.01 (-3.41%)
The current stock price of COSM is 0.4161 USD. In the past month the price increased by 23.09%. In the past year, price decreased by -37.57%.
COSM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 21.15 | 87.76B | ||
| COR | CENCORA INC | 19.36 | 55.62B | ||
| CAH | CARDINAL HEALTH INC | 18.59 | 35.93B | ||
| HSIC | HENRY SCHEIN INC | 14.41 | 8.45B | ||
| AHCO | ADAPTHEALTH CORP | 13.51 | 1.15B | ||
| AHG | AKSO HEALTH GROUP | N/A | 574.30M | ||
| OMI | OWENS & MINOR INC | 4.61 | 555.81M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 133.75M | ||
| ATPC | AGAPE ATP CORP | N/A | 80.02M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 4.55M |
Related stock screener links
About COSM
Company Profile
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. The company offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. The company is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Company Info
COSMOS HEALTH INC
5 Agiou Georgiou, Pilea
Thessaloniki ILLINOIS GR
Employees: 123
Phone: 303125363102
COSMOS HEALTH INC / COSM FAQ
What is the stock price of COSMOS HEALTH INC today?
The current stock price of COSM is 0.4161 USD. The price decreased by -3.41% in the last trading session.
What is the ticker symbol for COSMOS HEALTH INC stock?
The exchange symbol of COSMOS HEALTH INC is COSM and it is listed on the Nasdaq exchange.
On which exchange is COSM stock listed?
COSM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for COSMOS HEALTH INC stock?
7 analysts have analysed COSM and the average price target is 3.06 USD. This implies a price increase of 635.4% is expected in the next year compared to the current price of 0.4161. Check the COSMOS HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is COSMOS HEALTH INC worth?
COSMOS HEALTH INC (COSM) has a market capitalization of 11.35M USD. This makes COSM a Nano Cap stock.
How many employees does COSMOS HEALTH INC have?
COSMOS HEALTH INC (COSM) currently has 123 employees.
What are the support and resistance levels for COSMOS HEALTH INC (COSM) stock?
COSMOS HEALTH INC (COSM) has a support level at 0.42 and a resistance level at 0.45. Check the full technical report for a detailed analysis of COSM support and resistance levels.
Is COSMOS HEALTH INC (COSM) expected to grow?
The Revenue of COSMOS HEALTH INC (COSM) is expected to grow by 6.66% in the next year. Check the estimates tab for more information on the COSM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy COSMOS HEALTH INC (COSM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of COSM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of COSM, evaluating the profitability, health, valuation and growth aspects
- COSMOS HEALTH INC (COSM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COSMOS HEALTH INC (COSM) Sales and EPS estimates to see what analysts future expectations are.
- COSMOS HEALTH INC (COSM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COSMOS HEALTH INC (COSM) Insider and Institutional Ownership to learn about the owners and their transactions.
- COSMOS HEALTH INC (COSM) Stock Chart to make your own analysis
- COSMOS HEALTH INC (COSM) Latest news and press-releases to stay up to date.
Does COSMOS HEALTH INC (COSM) stock pay dividends?
COSM does not pay a dividend.
When does COSMOS HEALTH INC (COSM) report earnings?
COSMOS HEALTH INC (COSM) will report earnings on 2025-05-14.
What is the Price/Earnings (PE) ratio of COSMOS HEALTH INC (COSM)?
COSMOS HEALTH INC (COSM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.23).
What is the Short Interest ratio of COSMOS HEALTH INC (COSM) stock?
The outstanding short interest for COSMOS HEALTH INC (COSM) is 2.49% of its float. Check the ownership tab for more information on the COSM short interest.
COSM Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to COSM. When comparing the yearly performance of all stocks, COSM is a bad performer in the overall market: 89.42% of all stocks are doing better.
COSM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to COSM. Both the profitability and financial health of COSM have multiple concerns.
COSM Financial Highlights
Over the last trailing twelve months COSM reported a non-GAAP Earnings per Share(EPS) of -2.23. The EPS increased by 71.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -52.41% | ||
| ROE | -96.67% | ||
| Debt/Equity | 0.25 |
COSM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to COSM. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -21.87% and a revenue growth 6.66% for COSM